Search Within

Population Sciences Research Program

  1. "Peter Bach"
  2. "American Society of Clinical Oncology"
Formats
  1. Meeting Abstract (23)
  2. Journal Article (21)
  3. Review (1)
Groups
  1. Epidemiology and Biostatistics (45)
  2. Health Outcomes Research Group (45)
  3. Department of Medicine (23)
  4. Solid Tumor Oncology Division (20)
  5. Biostatistics Service (9)
  6. Gastrointestinal Oncology Service (6)

More Groups

People
  1. Peter Bach (45)
  2. Allison Lipitz Snyderman (11)
  3. Elena Elkin (10)
  4. Aaron Mitchell (6)
  5. Coral Atoria (6)
  6. Akriti Mishra (5)

More People

Years
  1. 2023 (1)
  2. 2022 (3)
  3. 2021 (1)
  4. 2020 (3)
  5. 2019 (5)
  6. 2018 (4)

More Years

Publications
  1. Journal of Clinical Oncology (36)
  2. Journal of Oncology Practice (8)
  3. JCO Clinical Cancer Informatics (1)
Publishers
  1. American Society of Clinical Oncology (45)

Results (45)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Oncologists' receipt of pharmaceutical industry payments and use of non-recommended and low-value cancer care services
    Meeting Abstract

    Mitchell, A. P.; Dusetzina, S. B.; Mishra Meza, A.; Trivedi, Niti U.; Bach, P. B.; Winn, A. N.
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Pharmaceutical industry payments to physicians for the promotion of cancer drugs
    Meeting Abstract

    Mitchell, A. P.; Mishra Meza, A.; Trivedi, N. U.; Bach, P. B.; Gonen, M.
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Cell-free DNA (cfDNA) fragmentomes predict tumor burden in metastatic colorectal cancer (mCRC)
    Meeting Abstract

    Leal, A.; van 't Erve, I.; Lumbard, K.; Keefer, L.; Carey, J.; Wu, T.; Jakubowski, D.; Butler, D.; Rongione, M.; Chesnick, B.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Use of bone modifying agents for metastatic castrate-resistant prostate cancer
    Meeting Abstract

    Mitchell, A. P.; Mishra Meza, A.; Farooki, A.; Panageas, K.; Bach, P. B.; Lipitz-Snyderman, A.; Morris, M. J.
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Use of bone modifying agents in patients with metastatic castrate-sensitive prostate cancer
    Meeting Abstract

    Mitchell, A. P.; Mishra, A. A.; Bach, P. B.; Morris, M. J.
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • The correlation between clinical benefit and financial cost of cancer drugs
    Meeting Abstract

    Mitchell, A. P.; Tabatabai, S.; Dey, P.; Ohn, J.; Curry, M. A.; Bach, P.
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • The association between drug industry payments and NCCN guideline panel membership
    Meeting Abstract

    Mitchell, A. P.; Mishra, A. A.; Dey, P.; Curry, M. A.; Trivedi, N. A.; Haddadin, M.; Rahman, M.; Winn, A. N.; Dusetzina, S.; Bach, P.
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Review of current policy strategies to reduce US cancer drug costs
    Review

    Green, A. K.; Ohn, J. A.; Bach, P. B.
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • A conundrum in cancer quality measurement: Performance on long-term survival reflects performance a long time ago
    Meeting Abstract

    Lipitz-Snyderman, A.; Curry, M. A.; Rubin, D. M.; Li, D. G.; Duck, E.; Radzyner, M. H.; Bach, P.
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Opportunity for performance measurement: 30-day mortality following cancer surgeries across US hospitals
    Meeting Abstract

    Lipitz-Snyderman, A.; Lavery, J. A.; Bach, P.; Li, D. G.; Yang, A.; Strong, V. E.; Russo, A.; Panageas, K.
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save